UiPath stock faces Cleveland Research warning on ARR risks
Published on 11/20/2026 at 22:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat the warning means
- Cleveland Research highlighted potential downside risks for UiPath's annual recurring revenue growth.
- Competition and corporate budget shifts toward artificial intelligence were identified as possible headwinds for the automation software company.
UiPath stock traded at 10.05 euros on Lang & Schwarz at 22:01 CET on Friday, November 20, 2026.
Cleveland Research flags ARR risks
On Wednesday, November 18, Cleveland Research issued a cautious assessment of UiPath's annual recurring revenue outlook. MyAllies News, citing Seeking Alpha, said the investment firm saw potential downside risks for ARR growth.
The analysis pointed to stronger competition and corporate budget shifts toward artificial intelligence as possible headwinds. That puts the development of UiPath's recurring-revenue base at the center of the current investment debate.
Recurring revenue remains central
ARR reflects annualized recurring commitments rather than revenue recognized during a single quarter. For investors, the distinction matters because ARR momentum can strengthen the longer-term revenue outlook while reported sales still depend on recognition timing and customer spending.
UiPath, Inc. at a glance
- ISIN: US90364P1057
- Ticker: PATH
- Lang & Schwarz quote: 10.05 euros on November 20, 2026, at 22:01 CET
The broader US market context is covered in current S&P 500 market reports.
